Abarceo Pharma
PrivateLast Round
VC Round
Oct 27, 2025
Total Funding Raised
$2.56M
Company Overview
Abarceo Pharma operates in Healthcare & Life Sciences and is based in Malmö. Its latest recorded funding round was a VC Round in October 2025.
Abarceo Pharma is a biotechnology company developing a small molecule technology platform for the treatment of mitochondrial dysfunction, with an initial focus on Type 2 Diabetes.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Abarceo Pharma Comparables
Compare Abarceo Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pharmasaga Co., Ltd. | 85% | |
| MitoRx Therapeutics | 81% | |
| Mito BioPharma | 77% |
For institutional investors. Book with your work email.
Abarceo Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Oct 27, 2025 | ||||
| Private Equity | Dec 6, 2024 | ||||
| Seed | Mar 1, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Abarceo Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cardeon AB | Private Equity |
| Almi Invest AB | Seed |
| LU Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 27, 2025
Raised a VC Round with investment from lsi-epsilon.
- May 1, 2025
Monthly visitors grew 230% MoM, reaching 1.7K.
For institutional investors. Book with your work email.
Abarceo Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Abarceo Pharma's valuation, stock price, and market status.
Is Abarceo Pharma a public or private company?
Abarceo Pharma is a private company.
What is the current stock price of Abarceo Pharma?
Abarceo Pharma is a private company, so its shares have no public market price. Caplight tracks Abarceo Pharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Abarceo Pharma worth (valuation)?
Valuation information for Abarceo Pharma is not publicly available.
Can I buy Abarceo Pharma stock?
Abarceo Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Abarceo Pharma's last funding round?
Abarceo Pharma's most recent funding round was VC Round on October 27, 2025.
Who are the main investors in Abarceo Pharma?
Key investors in Abarceo Pharma include Cardeon AB, Almi Invest AB.
Will Abarceo Pharma IPO soon?
No public IPO plans have been announced for Abarceo Pharma.
How can I track Abarceo Pharma secondary market activity?
Caplight tracks bids, offers, and trades in Abarceo Pharma's shares on secondary markets.